← Back to Search

Intervention group for Primary Biliary Cirrhosis

N/A
Waitlist Available
Led By Puneeta Tandon
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

The investigators have designed a guided, online, multicomponent, mind-body intervention for participants with primary biliary cholangitis. The ability of the online intervention to impact the primary and secondary outcome measures will be assessed as compared to control.

Eligible Conditions
  • Primary Biliary Cirrhosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
HADS Anxiety and Depression Scale
Secondary outcome measures
Capability, Opportunity, Motivation, Behavior (COM-B) Survey
Connor Davidson Resilience Scale 10
Lower Extremity Function Scale
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention groupExperimental Treatment1 Intervention
Participants will receive the standard of care for PBC and access to the online intervention. During the intervention period, participants will also receive weekly brief (~10-minute) motivational interview style telephone check-ins.
Group II: Wait list control groupActive Control1 Intervention
During the 12-week wait list period, participants will receive the standard of care for PBC in addition to weekly emails with motivational messages.

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
889 Previous Clinical Trials
385,051 Total Patients Enrolled
Puneeta TandonPrincipal InvestigatorUniversity of Alberta
3 Previous Clinical Trials
223 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~25 spots leftby Apr 2025